Furthermore, dividing into four subgroups according to the protein expression levels (negative, weakly positive, moderately positive and strongly positive groups); Aurora A mRNA median levels were 0.157, 0.228, 0.067 and 0.578, respectively (Additional file 1: Figure S3).
Furthermore, dividing stage IV patients into stage IVA (low grade with median survival 8 months) and stage IVB (high grade with median survival 5 months) provides better risk stratification in the very patient population most likely to enroll in future clinical trials to evaluate potential new therapies.
Furthermore, dividing all RTX-treated patients into those previously treated with TNF-inhibitors (n = 15) and patients not treated with TNF-inhibitors (n = 4) revealed no differences between these groups, suggesting that previous treatment with TNF inhibitors does not affect our results.
In the CDMBP method, cover image I size (512 times 512) is split into two regions X and Y( embedded region and non-embedded region. The region of X, we extracted from 8-bit plane to generate a CDMBP bit-plane image furthermore, CDMBP image divided into non-overlapping blocks with respect of zero point (ZP).
To examine the disease duration, patient groups were created in which the disease duration increased by 5 years in each group (0 5, 5 10, etc).. Furthermore, patients were divided into three groups by monthly attack frequency (rare: 0 1 attacks/month, average: 2 7 attacks/month, very frequent: 8 or more attacks/month).
Furthermore, participants were divided into four groups according to age and the seroprevalence in each was determined.
Furthermore, patients were divided into four groups based on both the median frequencies of Th17 and Th1 cells.
Furthermore, cases were divided into two subgroups with a leg lengthening/shortening of one centimetre or more than one centimetre, respectively.
Furthermore, patients were divided into two subgroups based on the age of epilepsy onset (before or after 10 years) to assess any correlations between their WM parameters and clinical variables.
